Timken director receives 2,270 share award
Timken Company director Christopher L. Mapes acquired 2,270 shares of Common Stock as a stock award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Timken Company director Christopher L. Mapes acquired 2,270 shares of Common Stock as a stock award. The shares were issued at no cash cost to him in connection with the vesting of 100% of time-based restricted share units granted on May 2, 2025. Following this vesting, he directly holds 30,585 Timken shares, reflecting routine equity compensation rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,270 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents vesting of 100% of the time-based restricted share units granted on May 2, 2025.
Key Figures
Key Terms
Form 4 regulatory
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Timken (TKR) director Christopher Mapes report in this Form 4?
Was the Timken (TKR) Form 4 transaction an open-market buy or sell?
Does the Timken (TKR) Form 4 indicate any derivative securities remaining for Christopher Mapes?
AI-generated analysis. How Rhea-AI works. Not financial advice.